GNMLF
Price:
$1.27
Market Cap:
$24.14B
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, U...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-05-04
Stock Exchange
PNK
Ticker
GNMLF
According to Genomma Lab Internacional, S.A.B. de C.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.58B. This represents a change of 27.42% compared to the average of 21.64B of the last 4 quarters.
The mean historical Enterprise Value of Genomma Lab Internacional, S.A.B. de C.V. over the last ten years is 23.30B. The current 27.58B Enterprise Value has changed 11.74% with respect to the historical average. Over the past ten years (40 quarters), GNMLF's Enterprise Value was at its highest in in the June 2017 quarter at 28.53B. The Enterprise Value was at its lowest in in the December 2017 quarter at 3.63B.
Average
23.30B
Median
23.56B
Minimum
16.43B
Maximum
35.16B
Discovering the peaks and valleys of Genomma Lab Internacional, S.A.B. de C.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 46.23%
Maximum Annual Enterprise Value = 35.16B
Minimum Annual Increase = -46.54%
Minimum Annual Enterprise Value = 16.43B
Year | Enterprise Value | Change |
---|---|---|
2023 | 18.30B | -15.65% |
2022 | 21.70B | -17.75% |
2021 | 26.38B | 12.29% |
2020 | 23.50B | -2.20% |
2019 | 24.02B | 46.23% |
2018 | 16.43B | -30.43% |
2017 | 23.62B | -5.89% |
2016 | 25.10B | 33.53% |
2015 | 18.79B | -46.54% |
2014 | 35.16B | -16.79% |
The current Enterprise Value of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.13B
5-year avg
22.78B
10-year avg
23.30B
Genomma Lab Internacional, S.A.B. de C.V.’s Enterprise Value is greater than RAMM Pharma Corp. (529.77K), greater than Speakeasy Cannabis Club Ltd. (2.88M), greater than City View Green Holdings Inc. (2.86M), greater than Craftport Cannabis Corp. (9.02B), greater than Hypera S.A. (19.33B), greater than Indivior PLC (1.50B), greater than YourWay Cannabis Brands Inc. (17.82M), greater than Cumberland Pharmaceuticals Inc. (39.26M), greater than Orexo AB (publ) (1.08B), less than Sumitomo Pharma Co., Ltd. (512.78B), greater than Indivior PLC (1.50B), greater than C21 Investments Inc. (33.98M), greater than RavenQuest BioMed Inc. (13.59M), greater than Bhang Inc. (-323622.00), greater than Willow Biosciences Inc. (9.55M), greater than Alpha Teknova, Inc. (482.89M), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Lifecore Biomedical, Inc. (411.23M), greater than Organogenesis Holdings Inc. (413.14M), greater than Petros Pharmaceuticals, Inc. (6.24M),
Company | Enterprise Value | Market cap |
---|---|---|
529.77K | $15.16M | |
2.88M | $1.31K | |
2.86M | $730.24K | |
9.02B | $6.27B | |
19.33B | $1.90B | |
1.50B | $2.89B | |
17.82M | $17.82M | |
39.26M | $35.25M | |
1.08B | $38.58M | |
512.78B | $1.64B | |
1.50B | $3.01B | |
33.98M | $21.97M | |
13.59M | $482.11K | |
-323622.00 | $23.48K | |
9.55M | $6.34M | |
482.89M | $458.45M | |
-10475955.00 | $4.35M | |
411.23M | $279.89M | |
413.14M | $399.81M | |
6.24M | $2.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomma Lab Internacional, S.A.B. de C.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genomma Lab Internacional, S.A.B. de C.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Genomma Lab Internacional, S.A.B. de C.V.'s Enterprise Value?
What is the highest Enterprise Value for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?
What is the 3-year average Enterprise Value for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?
What is the 5-year average Enterprise Value for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)?
How does the current Enterprise Value for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) compare to its historical average?